Marketing-authorisation holder · United States
Digestive Care, Inc.
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| PERTZYE15,125usp units; 4,000usp units; 14,375usp units | 30,250usp units; 8,000usp units; 28,750usp units | 60,500usp units; 16,000usp units; 57,500usp units | 90,750usp units; 24,000usp units; 86,250usp units · Capsule, delayed release | Pancrelipase (amylase, Lipase, Protease | United States | Marketed | 2012 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.